Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
- None.
- None.
Of the restricted stock granted, 22,182 shares will vest, subject to continued employment, over four years in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date, and 16,597 shares will vest, subject to continued employment, based on the achievement of the applicable performance targets and the same time-based vesting conditions as the other shares of restricted stock granted. The restricted stock is subject to the terms and conditions of the Inducement Plan and an award agreement covering each grant.
About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver outcomes-based medical care to patients in a cost-effective manner.
Headquartered in
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@apollomed.net
Asher Dewhurst, ICR Westwicke
ApolloMedIR@westwicke.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-announces-grant-of-inducement-awards-pursuant-to-nasdaq-listing-rule-5635c4-302018194.html
SOURCE Apollo Medical Holdings, Inc.
FAQ
What is the announcement made by Apollo Medical Holdings, Inc. (AMEH) on December 18, 2023?
What is the purpose of the Inducement Plan mentioned in the press release by Apollo Medical Holdings, Inc. (AMEH)?
How many shares will vest based on continued employment, and what are the vesting conditions?